Did kids catch COVID from parents? hospital worker family study reveals answers
NCT ID NCT04442087
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how many children of hospital workers had antibodies against the virus that causes COVID-19. Researchers tested blood and saliva samples from 563 family members to see if a parent's infection status affected the child's risk. The goal was to better understand how the virus spreads within families, especially when parents are exposed at work.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
563 people
The number who actually took part.
- Started
-
Jun 2020
- Finished
-
Apr 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Hospital workers : 1. Individuals aged over 18, having a professional activity at the APHP (employees, interns, volunteers) 2. Affiliated to a social security regimen 3. Have at least one child under the age of 18 living in the same house. 4. have signed consent Child (ren), spouse and other member (s) residing at household: Child (ren), spouse and any other member residing in the household of a professional of the Paris Center Hospitals meeting the inclusion criteria above. Exclusion Criteria: Refuse to participate in research
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield lungs from COVID-19's worst damage?
- French ICU study reveals COVID-19 patient outcomes
- Massive study reveals COVID-19 risks for autoimmune patients
- COVID infection study in hospital staff withdrawn before start
- Can early COVID-19 drugs keep high-risk patients out of the hospital?
- COVID-19 ICU patients may face higher superbug risk